- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
股价的强势特征已经确立，短线可能回调。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
已有71家主力机构披露2025-12-31报告期持股数据，持仓量总计1.51亿股，占流通A股32.35%
- 波段诊断：
-
技术面诊股
诊断结果：6.1技术面打败了73%的股票
技术面评分前10的股票
近期的平均成本为19.77元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为19.77元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"19.77","date":1783239415,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑赢大盘，跑赢行业平均水平。
[{"date":"2026.07.06","stock":"4.80","trade":null,"ind":"-0.06"},{"date":"2026.07.03","stock":"3.11","trade":null,"ind":"0.37"},{"date":"2026.07.02","stock":"0.17","trade":null,"ind":"-2.03"},{"date":"2026.07.01","stock":"4.97","trade":null,"ind":"0.44"},{"date":"2026.06.30","stock":"-2.51","trade":null,"ind":"0.50"},{"date":"2026.06.29","stock":"4.84","trade":null,"ind":"1.16"},{"date":"2026.06.26","stock":"-4.51","trade":null,"ind":"-2.26"},{"date":"2026.06.25","stock":"-1.52","trade":null,"ind":"0.23"},{"date":"2026.06.24","stock":"-3.16","trade":null,"ind":"0.11"},{"date":"2026.06.23","stock":"2.17","trade":null,"ind":"-1.37"},{"date":"2026.06.22","stock":"-1.96","trade":null,"ind":"1.78"},{"date":"2026.06.18","stock":"0.82","trade":null,"ind":"-0.43"},{"date":"2026.06.17","stock":"-1.89","trade":null,"ind":"0.40"},{"date":"2026.06.16","stock":"0.38","trade":null,"ind":"-0.11"},{"date":"2026.06.15","stock":"-1.28","trade":null,"ind":"1.61"},{"date":"2026.06.12","stock":"2.91","trade":null,"ind":"1.12"},{"date":"2026.06.11","stock":"-1.78","trade":null,"ind":"-0.16"},{"date":"2026.06.10","stock":"-1.80","trade":null,"ind":"-0.42"},{"date":"2026.06.09","stock":"0.32","trade":null,"ind":"1.28"},{"date":"2026.06.08","stock":"-5.19","trade":null,"ind":"-1.70"},{"date":"2026.06.05","stock":"1.95","trade":null,"ind":"-0.74"}]
中源协和,上证指数,医疗器械指数
压力支撑
该股压力位为19.66元，支撑位为18.97元。
[{"text":"\u538b\u529b\u4f4d","value":"19.66","date":1783267200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"18.97","date":1783267200,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.2资金面打败了9%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体无进出。
更新时间：07月06日 20:31
| 机构今日流向(万元) | -462.51 | 机构5日流向(万元) | -267.46 |
| 机构10日流向(万元) | -2931.24 | 机构20日流向(万元) | -8024.91 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量减少421.81万股，其中基金净减仓11家，主力净减仓4家，请投资者中长期谨慎为宜。
截止2025-12-31，共71家主力机构（基金67家，一般法人4家），持仓量总计15132.63万股，占流通A股32.35%
其中，基金持仓与2025-06-30相比：
增仓：18家 ，增持 153.16万股
减仓：29家 ，减持 532.84万股
新出现在主力名单中：19家 ，持有47.34万股
从主力名单中消失：23家 ，原持有231.69万股
其中，基金持仓与2025-06-30相比：
增仓：18家 ，增持 153.16万股
减仓：29家 ，减持 532.84万股
新出现在主力名单中：19家 ，持有47.34万股
从主力名单中消失：23家 ，原持有231.69万股
消息面诊股
诊断结果：5.5消息面打败了55%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 2026年中国病理诊断行业龙头企业分析 迈新生物：
2026-07-06 - 机器人+存储芯片+卫星互联网+干细胞+洁净室，最直
2026-07-06 - 中源协和：7月3日获融资买入1975.08万元
2026-07-04 - 中源协和旗下天津市脐血库脐血应用总量已达4138例
2026-07-03 - 中源协和：7月2日获融资买入1628.37万元
2026-07-03 - 中源协和：7月1日获融资买入1899.86万元
2026-07-02 - 中源协和：6月30日获融资买入1107.17万元
2026-07-01 - 中源协和：6月29日获融资买入2319.57万元
2026-06-30 - 创新药，迎重要制度红利！
2026-06-29 - 中源协和：6月26日获融资买入1928.41万元
2026-06-27
消息列表
| 一般消息 | 募资投向 | 2026-06-05 | |
| 一般消息 | 股东大会 | 年度股东大会 | 2026-04-25 |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-04-25 |
| 一般消息 | 重大事项 | 关联交易 | 2026-04-25 |
| 一般消息 | 高管变动 | 不在担任 | 2025-12-25 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-12-15 |
| 一般消息 | 高管变动 | 委员会更名 | 2025-11-26 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-28 |
| 一般消息 | 重大事项 | 关联交易 | 2025-08-28 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 0条 | 0条 | 0条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：3.5行业面打败了55%的股票
医疗器械行业最新资金流向
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
[{"date":"2026.07.06","price":"-0.06","value":null},{"date":"2026.07.03","price":"0.37","value":null},{"date":"2026.07.02","price":"-2.03","value":null},{"date":"2026.07.01","price":"0.44","value":null},{"date":"2026.06.30","price":"0.50","value":null},{"date":"2026.06.29","price":"1.16","value":null},{"date":"2026.06.26","price":"-2.26","value":null},{"date":"2026.06.25","price":"0.23","value":null},{"date":"2026.06.24","price":"0.11","value":null},{"date":"2026.06.23","price":"-1.37","value":null},{"date":"2026.06.22","price":"1.78","value":null},{"date":"2026.06.18","price":"-0.43","value":null},{"date":"2026.06.17","price":"0.40","value":null},{"date":"2026.06.16","price":"-0.11","value":null},{"date":"2026.06.15","price":"1.61","value":null},{"date":"2026.06.12","price":"1.12","value":null},{"date":"2026.06.11","price":"-0.16","value":null},{"date":"2026.06.10","price":"-0.42","value":null},{"date":"2026.06.09","price":"1.28","value":null},{"date":"2026.06.08","price":"-1.70","value":null},{"date":"2026.06.05","price":"-0.74","value":"-357279036.44"}]
上证指数,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 热景生物 | 65.64% | 59.03% | 5.6分 |
| 2 | 爱迪特 | 53.45% | -13.44% | 4.1分 |
| 3 | 迈普医学 | 23.10% | 10.65% | 5.2分 |
| 4 | 正川股份 | 22.14% | 0.89% | 5.5分 |
| 5 | 乐心医疗 | 20.81% | 14.72% | 5.1分 |
| 6 | 伟思医疗 | 20.56% | 5.24% | 5.6分 |
| 8 | 赛科希德 | 16.86% | -0.21% | 5.0分 |
| 10 | - | 14.19% | 10.49% | 分 |
| 12 | 华大智造 | 13.87% | 10.90% | 5.7分 |
| 14 | 洁特生物 | 12.98% | -3.07% | 3.9分 |
| 16 | 祥生医疗 | 12.22% | 15.40% | 6.1分 |
| 18 | 仁度生物 | 10.73% | -5.19% | 4.1分 |
| 20 | 振德医疗 | 10.19% | -1.33% | 5.8分 |
| 22 | 冠昊生物 | 8.12% | 5.18% | 4.5分 |
| 24 | 乐普医疗 | 6.92% | 5.68% | 5.5分 |
| 26 | 翔宇医疗 | 6.04% | 19.22% | 5.6分 |
| 28 | 拱东医疗 | 5.52% | -0.87% | 5.7分 |
| 30 | 南微医学 | 4.65% | 2.77% | 5.8分 |
| 32 | 东富龙 | 4.32% | 4.97% | 4.9分 |
| 34 | 安杰思 | 3.19% | 6.87% | 5.6分 |
| 36 | 康为世纪 | 2.69% | -4.17% | 4.0分 |
| 38 | 奥美医疗 | 2.06% | 1.40% | 4.9分 |
| 40 | ST凯利 | 1.79% | 2.96% | 5.0分 |
| 42 | 浩欧博 | 0.71% | 4.44% | 5.1分 |
| 44 | 济民健康 | 0.58% | 13.02% | 4.5分 |
| 46 | 安图生物 | 0.10% | 4.11% | 5.6分 |
| 48 | 圣湘生物 | -0.07% | 2.93% | 5.3分 |
| 50 | 三诺生物 | -0.20% | 6.19% | 5.5分 |
| 52 | 南卫股份 | -0.75% | 1.94% | 6.3分 |
| 54 | 英科医疗 | -0.93% | 14.54% | 5.2分 |
| 56 | 三友医疗 | -1.25% | 6.64% | 4.8分 |
| 58 | 九强生物 | -1.84% | 4.17% | 5.4分 |
| 60 | 昊海生科 | -1.92% | 6.38% | 5.0分 |
| 62 | 中源协和 | -1.97% | 10.77% | 4.9分 |
| 64 | 迈克生物 | -2.31% | 6.09% | 4.7分 |
| 66 | 戴维医疗 | -2.49% | 0.62% | 4.2分 |
| 68 | 易瑞生物 | -2.63% | 6.61% | 4.2分 |
| 70 | 美康生物 | -2.82% | 4.10% | 4.6分 |
| 72 | 理邦仪器 | -3.08% | 0.96% | 5.6分 |
| 74 | 华兰股份 | -3.40% | -5.70% | 4.3分 |
| 76 | 新华医疗 | -3.57% | 1.89% | 5.5分 |
| 78 | 澳华内镜 | -3.79% | -4.47% | 5.0分 |
| 80 | 赛诺医疗 | -4.15% | -0.43% | 4.7分 |
| 82 | 爱博医疗 | -4.52% | 4.95% | 5.2分 |
| 84 | 山东药玻 | -5.13% | 2.19% | 5.8分 |
| 86 | 尚荣医疗 | -5.25% | 5.86% | 4.7分 |
| 88 | 国发股份 | -5.48% | -0.51% | 4.1分 |
| 90 | 天臣医疗 | -5.59% | 2.48% | 4.6分 |
| 92 | - | -5.86% | -3.34% | 分 |
| 94 | - | -5.97% | 2.35% | 分 |
| 96 | 亚辉龙 | -6.09% | 3.70% | 4.9分 |
| 98 | 威高骨科 | -6.16% | 4.53% | 5.5分 |
| 100 | - | -6.30% | 1.16% | 分 |
| 102 | 超研股份 | -6.56% | 2.90% | 4.9分 |
| 104 | 健尔康 | -6.93% | 3.39% | 4.7分 |
| 106 | 华强科技 | -7.03% | 6.27% | 4.0分 |
| 108 | 黄山胶囊 | -7.27% | 4.69% | 4.5分 |
| 110 | 安必平 | -8.64% | 5.08% | 4.5分 |
| 112 | 麦克奥迪 | -9.74% | 1.52% | 5.5分 |
| 114 | 中红医疗 | -10.23% | 6.31% | 4.6分 |
| 116 | 九安医疗 | -10.44% | -5.28% | 5.0分 |
| 118 | - | -10.74% | -1.42% | 分 |
| 120 | 奥泰生物 | -11.46% | 5.55% | 4.1分 |
| 122 | 健信超导 | -11.91% | 3.52% | 5.8分 |
| 124 | 康众医疗 | -12.12% | -3.10% | 5.1分 |
| 126 | 蓝帆医疗 | -12.30% | 1.71% | 4.9分 |
| 128 | 之江生物 | -12.65% | 2.06% | 4.4分 |
| 130 | *ST海利 | -12.76% | 10.53% | 3.9分 |
| 132 | 万东医疗 | -12.92% | 3.78% | 4.7分 |
| 134 | 万泰生物 | -14.38% | 5.43% | 4.6分 |
| 136 | *ST益通 | -15.37% | 5.54% | 4.0分 |
| 138 | 康拓医疗 | -16.83% | -1.75% | 4.6分 |
| 140 | - | - | -28.25% | 分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2026-03-31 ]公司经营
盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 80/244 ， 25/244。
[{"date":"2026-03-31","value":"0.65","vol":"1.12"},{"date":"2025-12-31","value":"3.12","vol":"2.37"},{"date":"2025-09-30","value":"2.95","vol":"3.06"},{"date":"2025-06-30","value":"1.59","vol":"2.40"},{"date":"2025-03-31","value":"0.78","vol":"1.17"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
0.65 | 3.12 | 2.95 | 1.59 | 0.78 |
| 行业(%) | 1.12 | 2.37 | 3.06 | 2.40 | 1.17 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"69.57","vol":"52.12"},{"date":"2025-12-31","value":"69.84","vol":"51.82"},{"date":"2025-09-30","value":"69.22","vol":"52.03"},{"date":"2025-06-30","value":"68.70","vol":"52.36"},{"date":"2025-03-31","value":"68.32","vol":"51.96"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
69.57 | 69.84 | 69.22 | 68.70 | 68.32 |
| 行业(%) | 52.12 | 51.82 | 52.03 | 52.36 | 51.96 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 103/244 ， 75/244。
[{"date":"2026-03-31","value":"-9.54","vol":"5.59"},{"date":"2025-12-31","value":"-8.23","vol":"1.01"},{"date":"2025-09-30","value":"-9.41","vol":"0.11"},{"date":"2025-06-30","value":"-10.71","vol":"-1.37"},{"date":"2025-03-31","value":"-11.86","vol":"-0.45"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-9.54 | -8.23 | -9.41 | -10.71 | -11.86 |
| 行业(%) | 5.59 | 1.01 | 0.11 | -1.37 | -0.45 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"-13.50","vol":"-20.93"},{"date":"2025-12-31","value":"13.43","vol":"-33.44"},{"date":"2025-09-30","value":"-19.18","vol":"-15.21"},{"date":"2025-06-30","value":"-32.18","vol":"-17.88"},{"date":"2025-03-31","value":"-30.18","vol":"-2.61"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-13.50 | 13.43 | -19.18 | -32.18 | -30.18 |
| 行业(%) | -20.93 | -33.44 | -15.21 | -17.88 | -2.61 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 84/244 ， 76/244。
[{"date":"2026-03-31","value":"0.06","vol":"0.08"},{"date":"2025-12-31","value":"0.28","vol":"0.35"},{"date":"2025-09-30","value":"0.21","vol":"0.25"},{"date":"2025-06-30","value":"0.14","vol":"0.17"},{"date":"2025-03-31","value":"0.07","vol":"0.08"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.06 | 0.28 | 0.21 | 0.14 | 0.07 |
| 行业(次) | 0.08 | 0.35 | 0.25 | 0.17 | 0.08 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.42","vol":"0.55"},{"date":"2025-12-31","value":"1.90","vol":"2.33"},{"date":"2025-09-30","value":"1.43","vol":"1.66"},{"date":"2025-06-30","value":"0.96","vol":"1.12"},{"date":"2025-03-31","value":"0.47","vol":"0.54"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.42 | 1.90 | 1.43 | 0.96 | 0.47 |
| 行业(次) | 0.55 | 2.33 | 1.66 | 1.12 | 0.54 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-03-31","value":"8.87","vol":"-0.33"},{"date":"2025-12-31","value":"25.04","vol":"32.14"},{"date":"2025-09-30","value":"26.54","vol":"14.86"},{"date":"2025-06-30","value":"20.96","vol":"15.69"},{"date":"2025-03-31","value":"13.23","vol":"4.55"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 8.87 | 25.04 | 26.54 | 20.96 | 13.23 |
| 行业 | -0.33 | 32.14 | 14.86 | 15.69 | 4.55 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.30","vol":"1.62"},{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"0.29","vol":"1.58"},{"date":"2025-03-31","value":"","vol":"0.00"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.30 | - | 0.29 | - |
| 行业 | 0.00 | 1.62 | 0.01 | 1.58 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 4/244 ， 29/244。
[{"date":"2026-03-31","value":"1.88","vol":"6.17"},{"date":"2025-12-31","value":"1.82","vol":"5.27"},{"date":"2025-09-30","value":"1.76","vol":"5.64"},{"date":"2025-06-30","value":"1.73","vol":"5.45"},{"date":"2025-03-31","value":"1.70","vol":"5.78"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
1.88 | 1.82 | 1.76 | 1.73 | 1.70 |
| 行业 | 6.17 | 5.27 | 5.64 | 5.45 | 5.78 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"1.65","vol":"5.04"},{"date":"2025-12-31","value":"1.61","vol":"4.13"},{"date":"2025-09-30","value":"1.56","vol":"4.49"},{"date":"2025-06-30","value":"1.52","vol":"4.34"},{"date":"2025-03-31","value":"1.48","vol":"4.68"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
1.65 | 1.61 | 1.56 | 1.52 | 1.48 |
| 行业 | 5.04 | 4.13 | 4.49 | 4.34 | 4.68 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 35/244 ， 38/244。
[{"date":"2026-03-31","value":"28.45","vol":"22.26"},{"date":"2025-12-31","value":"29.05","vol":"23.19"},{"date":"2025-09-30","value":"29.26","vol":"22.23"},{"date":"2025-06-30","value":"29.41","vol":"22.18"},{"date":"2025-03-31","value":"29.84","vol":"21.17"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
28.45 | 29.05 | 29.26 | 29.41 | 29.84 |
| 行业(%) | 22.26 | 23.19 | 22.23 | 22.18 | 21.17 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.40","vol":"0.40"},{"date":"2025-12-31","value":"0.41","vol":"0.41"},{"date":"2025-09-30","value":"0.42","vol":"0.72"},{"date":"2025-06-30","value":"0.42","vol":"0.58"},{"date":"2025-03-31","value":"0.43","vol":"0.56"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.40 | 0.41 | 0.42 | 0.42 | 0.43 |
| 行业(%) | 0.40 | 0.41 | 0.72 | 0.58 | 0.56 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2026年的收益，请投资者后续关注。
[{"date":"2022","yellowRectValue":"1.13","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"1.06","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"1.00","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"1.14","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]